These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

243 related items for PubMed ID: 9284597

  • 1. Rationale for the use of a low molecular weight heparin during hemodialysis with polysulphone membrane in uremic patients.
    Moia M, Graziani G, Tenconi PM, Martinelli I, Ponticelli C.
    Ann Ital Med Int; 1997; 12(2):67-71. PubMed ID: 9284597
    [Abstract] [Full Text] [Related]

  • 2. Comparison of anticoagulation efficacy and clinical safety between imported and domestically manufactured low-molecular-weight heparin during hemodialysis.
    Liu ZQ, Wang L.
    Di Yi Jun Yi Da Xue Xue Bao; 2002 Oct; 22(10):942-3. PubMed ID: 12377628
    [Abstract] [Full Text] [Related]

  • 3. A low molecular heparin fraction as an anticoagulant during hemodialysis.
    Ljungberg B.
    Clin Nephrol; 1985 Jul; 24(1):15-20. PubMed ID: 4017295
    [Abstract] [Full Text] [Related]

  • 4. Effective anticoagulation by a low molecular weight heparin (Fragmin) in hemodialysis with a highly permeable polysulfone membrane.
    Ljungberg B, Jacobson SH, Lins LE, Pejler G.
    Clin Nephrol; 1992 Aug; 38(2):97-100. PubMed ID: 1325310
    [Abstract] [Full Text] [Related]

  • 5. Clinical application of Fragmin (FR-860) in hemodialysis: multicenter cooperative study in Japan.
    Suzuki T, Ota K, Naganuma S, Koshikawa S, Hirasawa Y, Nakagawa S, Otsubo O, Akizawa T.
    Semin Thromb Hemost; 1990 Oct; 16 Suppl():46-54. PubMed ID: 1962904
    [Abstract] [Full Text] [Related]

  • 6. Low molecular weight heparin does not necessarily reduce lipids and lipoproteins in hemodialysis patients.
    Kronenberg F, König P, Lhotta K, Steinmetz A, Dieplinger H.
    Clin Nephrol; 1995 Jun; 43(6):399-404. PubMed ID: 7554525
    [Abstract] [Full Text] [Related]

  • 7. Acute effect of standard heparin versus low molecular weight heparin on oxidative stress and inflammation in hemodialysis patients.
    Poyrazoglu OK, Dogukan A, Yalniz M, Seckin D, Gunal AL.
    Ren Fail; 2006 Jun; 28(8):723-7. PubMed ID: 17162433
    [Abstract] [Full Text] [Related]

  • 8. Central venous catheter sampling of low molecular heparin levels: an approach to increasing result reliability.
    Bauman ME, Belletrutti M, Bauman ML, Massicotte MP.
    Pediatr Crit Care Med; 2012 Jan; 13(1):1-5. PubMed ID: 21317677
    [Abstract] [Full Text] [Related]

  • 9. [Anticoagulation in hemodialysis with a single dose of low molecular weight heparin].
    Vukusich A, Avalos C, Orellana G, Cifuentes C, Rivas J, Calderón F.
    Rev Med Chil; 1995 Jun; 123(6):735-41. PubMed ID: 8525227
    [Abstract] [Full Text] [Related]

  • 10. In vitro and in vivo evaluation of enoxaparin removal by continuous renal replacement therapies with acrylonitrile and polysulfone membranes.
    Isla A, Gascón AR, Maynar J, Arzuaga A, Corral E, Martín A, Solinís MA, Muñoz JL.
    Clin Ther; 2005 Sep; 27(9):1444-51. PubMed ID: 16291417
    [Abstract] [Full Text] [Related]

  • 11. Frequency of anti-heparin-PF4 complex antibodies (HIT antibodies) in uremic patients on chronic intermittent hemodialysis.
    Matsuo T, Kobayashi H, Matsuo M, Wanaka K, Nakamoto H, Matsushima H, Sakai R.
    Pathophysiol Haemost Thromb; 2006 Sep; 35(6):445-50. PubMed ID: 17565238
    [Abstract] [Full Text] [Related]

  • 12. [Cystatin C, beta2-microglobulin and C-reactive protein in hemodiafiltration and on-line endogenous liquid reinfusion and in low flux polysulphone bicarbonate conventional hemodialysis].
    Cristofano C, Vernaglione L, Perniola MA, Lo Barco C, Muscogiuri P, Chimienti S.
    G Ital Nefrol; 2004 Sep; 21 Suppl 30():S197-200. PubMed ID: 15750984
    [Abstract] [Full Text] [Related]

  • 13. The anticoagulant and hemorrhagic effects of DHG, a new depolymerized holothurian glycosaminoglycan, on experimental hemodialysis in dogs.
    Minamiguchi K, Kitazato KT, Sasaki E, Nagase H, Kitazato K.
    Thromb Haemost; 1997 Jun; 77(6):1148-53. PubMed ID: 9241748
    [Abstract] [Full Text] [Related]

  • 14. [The resistance of activated partial thromboplastin time to heparin infusion during hemodialysis].
    Camici M, Sagripanti A, Barsotti G, Baicchi U, Evangelisti L, Morelli E, Giovannetti S.
    Minerva Med; 1995 Sep; 86(9):353-5. PubMed ID: 7501225
    [Abstract] [Full Text] [Related]

  • 15. Comparison of the effects of low-molecular-weight and unfractioned heparin in horses.
    Monreal L, Villatoro AJ, Monreal M, Espada Y, Anglés AM, Ruiz-Gopegui R.
    Am J Vet Res; 1995 Oct; 56(10):1281-5. PubMed ID: 8928943
    [Abstract] [Full Text] [Related]

  • 16. Safety and efficacy anticoagulation in extracorporeal hemodialysis by simultaneous administration of low-dose prostacyclin and low molecular weight heparin.
    Camici M, Giordani R, Morelli E, Meriggioli M, Balestri PL, Barsotti G, Sagripanti A.
    Minerva Med; 1998 Oct; 89(11-12):405-9. PubMed ID: 10212664
    [Abstract] [Full Text] [Related]

  • 17. [Minimal heparinization in dialysis patients with increased risk of bleeding].
    Klingel R, Wandel E, Hafner G, Meyer zum Büschenfelde KH, Köhler H.
    Dtsch Med Wochenschr; 1993 Dec 23; 118(51-52):1878-83. PubMed ID: 8287777
    [Abstract] [Full Text] [Related]

  • 18. Low molecular weight heparin in hemodialysis patients with a bleeding tendency.
    Leu JG, Chiang SS, Lin SM, Pai JK, Jiang WW.
    Nephron; 2000 Dec 23; 86(4):499-501. PubMed ID: 11124600
    [Abstract] [Full Text] [Related]

  • 19. Anticoagulative effects of the inhaled low molecular weight heparin certoparin in healthy subjects.
    Scheuch G, Brand P, Meyer T, Herpich C, Müllinger B, Brom J, Weidinger G, Kohlhäufl M, Häussinger K, Spannagl M, Schramm W, Siekmeier R.
    J Physiol Pharmacol; 2007 Nov 23; 58 Suppl 5(Pt 2):603-14. PubMed ID: 18204174
    [Abstract] [Full Text] [Related]

  • 20. Effect of low molecular weight heparin on coagulation parameters and bleeding time in healthy volunteers.
    Warning A, Nies D, Wolf H, Welzel D.
    Arzneimittelforschung; 1987 Jul 23; 37(7):847-9. PubMed ID: 2823841
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.